SCHEMBL25074005

SCHEMBL25074005

CN1CCN(C(=O)[C@H]2CCN(C)C2)CC1

nearest known ligand 0.59

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
HTT P42858 1/20 0.59
LMNA P02545 1/20 0.58
NAMPT P43490 2/20 0.47
ALDH1A1 P00352 1/20 0.47
TSHR P16473 1/20 0.47
POLB P06746 2/20 0.46
CYP1A2 P05177 1/20 0.45
TDP1 Q9NUW8 1/20 0.45
PPP5C P53041 2/20 0.45
PPP2CA P67775 1/20 0.45
TFPI2 P48307 1/20 0.45
NPY4R P50391 1/20 0.45
KMT2A Q03164 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
HPGD P15428 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25074346 1.00 HTT (0.59) HTTLMNANAMPTALDH1A1TSHR
SCHEMBL14471382 1.00 HTT (0.59) HTTLMNANAMPTALDH1A1TSHR
SCHEMBL8194135 0.90 HTT (0.71) HTTLMNAALDH1A1TSHRPOLB
SCHEMBL3436956 0.89 LMNA (0.69) HTTLMNAALDH1A1TSHRPOLB
SCHEMBL18390513 0.88 HPGD (0.57) HTTLMNANAMPTALDH1A1TSHR
SCHEMBL26042922 0.88 L3MBTL3 (0.52) HTTLMNANAMPTALDH1A1TSHR
SCHEMBL24207819 0.88 L3MBTL3 (0.52) HTTLMNANAMPTALDH1A1TSHR
SCHEMBL26162910 0.87 HTT (0.46) HTTLMNANAMPTALDH1A1TSHR
SCHEMBL16838101 0.85 HTT (0.60) HTTLMNAALDH1A1TSHRPOLB
SCHEMBL12424259 0.85 NAMPT (0.45) HTTLMNANAMPTALDH1A1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023023255-A1 BIFUNCTIONAL DEGRADERS OF INTERLEUKIN-1 RECEPTOR-ASSOCIATED KINASES AND THERAPEUTIC USE THEREOF NURIX THERAPEUTICS, INC. (US) 2023-02-23 WO disclosed